PRIA Logo™
119-hr-10569119th Congress

Protecting Biotechnology and Biomanufacturing as Critical Infrastructure Act

Sponsored By: Representative Khanna, Ro [D-CA-17]

Introduced

Summary

Elevates biotechnology and biomanufacturing as critical infrastructure. This bill would require the Department of Homeland Security and the Cybersecurity and Infrastructure Security Agency to treat biotech and biomanufacturing owners and operators as part of the nation’s critical infrastructure and to expand staffing, planning, and risk analysis for sectors that lack a designated Sector-Specific Agency.

Show full summary
  • Biotech companies and facility operators would be brought into federal critical infrastructure planning and risk assessments and would receive targeted outreach and technical assistance from designated DHS staff.
  • Industry groups and information-sharing organizations would be formally included in assessments and coordination. The bill names BIO-ISAC and H-ISAC and requires DHS to work with industry associations for information sharing and risk management.
  • DHS would have to submit a work plan to Congress within 45 days and update strategic plans with biotech input by September 30, 2027. The work plan must identify stakeholders, outline outreach, and set a path for stakeholder representation in sector coordination.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

More protection for biotech facilities

If enacted, the bill would require CISA to treat biotechnology and biomanufacturing owners and operators as critical infrastructure stakeholders. CISA would have to assign staff to analyze risks, provide technical help, and carry out outreach. Assessments would need coordination with BIO-ISAC, H-ISAC, and industry associations. The CISA Director would have to send a work plan to House and Senate homeland security committees within 45 days, update strategic plans by September 30, 2027, send an implementation report one year after the work plan, and report on any remaining unprotected biotech areas by the earlier of two years after the work plan or the first evaluation under 6 U.S.C. 652a(b)(2) after enactment.

Sponsors & CoSponsors

Sponsor

Khanna, Ro [D-CA-17]

CA • D

Cosponsors

  • Rep. Bice, Stephanie I. [R-OK-5]

    OK • R

    Sponsored 9/24/2026

  • Rep. Peters, Scott H. [D-CA-50]

    CA • D

    Sponsored 9/24/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation